一般演題口演 糸球体・間質疾患（臨床）1

[O-045] Povetacicept, an Enhanced Dual BAFF ＆ APRIL Antagonist, in Autoantibody-Associated Glomerulonephritis

^○Jiahua Li¹, Jonathan Barratt², Harmeet Singh³, Inwhee Park⁴, Arvind Madan⁵, Sreedhar Mandayam⁶, Hemant Kulkarni⁷, Sang-Woong Han⁸, Sung Gyun Kim⁹, Rupert Davies¹, Amanda Enstrom¹, Heather Thomas¹, Stanford L. Peng¹, James Tumlin¹⁰ (1.Alpine Immune Sciences, 2.University of Leicester, 3.Western Nephrology, 4.Ajou University School of Medicine, 5.Central Florida Kidney Specialists, 6.University of Texas MD Anderson Cancer Center, 7.East Metropolitan Health Services, 8.Hanyang University Guri Hospital, 9.Hallyn University Sacred Heart Hospital, 10.NephroNet Clinical Trials Consortium)